TEVA
Teva Pharma Industries Ltd ADR
NYSE: TEVA · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$35.07
-0.88% today
Updated 2026-04-30
Market cap
$41.20B
P/E ratio
26.40
P/S ratio
2.39x
EPS (TTM)
$1.34
Dividend yield
—
52W range
$15 – $37
Volume
6.8M
Teva Pharma Industries Ltd ADR (TEVA) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $2.06B | $1.81B | $3.23B | $3.37B | $4.14B | $4.13B | $4.57B | $3.24B | $5.13B | $5.54B | $5.22B | $3.51B | $2.45B | $538.00M | $1.22B | $798.00M | $1.59B | $1.37B | $1.25B | $1.65B |
| Capital expenditures | $390.00M | $542.00M | $681.00M | $719.00M | $710.00M | $1.05B | $1.10B | $1.03B | $929.00M | $772.00M | $901.00M | $874.00M | $651.00M | $119.00M | $578.00M | $562.00M | $548.00M | $526.00M | $498.00M | $501.00M |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $48.00M | $67.00M | $63.00M | $54.00M | $80.00M | $91.00M | $82.00M | $64.00M | $95.00M | $117.00M | $124.00M | $133.00M | $155.00M | $20.00M | $129.00M | $119.00M | $124.00M | $121.00M | $123.00M | $157.00M |
| Free cash flow | $1.67B | $1.27B | $2.55B | $2.65B | $3.43B | $3.08B | $3.47B | $2.21B | $4.20B | $4.77B | $4.32B | $2.63B | $1.79B | $419.00M | $638.00M | $236.00M | $1.04B | $842.00M | $749.00M | $1.15B |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | $229.00M | $299.00M | $388.00M | $528.00M | $668.00M | $800.00M | $855.00M | $1.09B | $1.16B | $1.16B | $1.56B | $1.16B | $22.00M | $52.00M | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — | — | $-25.00M | $961.00M | $177.00M | $194.00M | $149.00M | — | — | — | — |